Stage IV CRC: The Evolving Role of Molecular Subtype
Dr. Overman on Molecular Subtypes in CRCПодробнее
Colon Cancer CarcinogensisПодробнее
Image-based consensus molecular subtypes of colorectal cancer: Korsuk Sirinukunwattana, 19/12/22Подробнее
Role of Molecular Testing in CRC ManagementПодробнее
Molecular Classification of Colon Cancer: New InsightsПодробнее
Treating Stage IV Right-Sided CRC Beyond ProgressionПодробнее
Molecular Testing for Metastatic CRC in 2020Подробнее
Keynote Lecture 4: The BRAF pathway in CRC?Подробнее
Diagnosing and Managing Stage IV Right-Sided CRCПодробнее
Frontline Therapy for Stage IV Right-Sided CRCПодробнее
Dr. Venook on Distinguishing Molecular Features in CRCПодробнее
Stage IV Colon Cancer Patient Tells His StoryПодробнее
Precision Medicine Further Explored in Metastatic CRCПодробнее
Colorectal Cancer: The Link Between the Immune Microenvironment and OutcomesПодробнее
Molecular Markers for Guiding Colorectal Cancer TherapyПодробнее
Colorectal Cancer: From Disparities to a New Molecular Subtype Associated with Early Age OnsetПодробнее
What is the current state of molecular profiling for colorectal cancer?Подробнее
Update 3: Molecular Subtyping in Colorectal CancerПодробнее
Biomarkers for treatment selection in colon cancerПодробнее